Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy ...
MSI's new MAG 321CUPDF gaming monitor launches in China: 31.5-inch VA panel, offering 4K 160Hz and 1080p 320Hz through its ...
The drug combo is the first dual checkpoint inhibitor therapy approved in Europe for first-line metastatic MSI-H or dMMR colorectal cancer.
Zacks.com on MSN1d
BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal CancerThe European Commission approves Bristol Myers' Opdivo plus Yervoy for first-line treatment of MSI-H or dMMR unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results